We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oxford Genetics Receives $500,000 in Innovate UK Funding

News   Feb 15, 2017 | Original Story From Oxford Genetics

 
Oxford Genetics Receives $500,000 in Innovate UK Funding
 
 
 

RELATED ARTICLES

Clinical Trial Results: Immune Therapy Reduces Risk of Aggressive Breast Cancer Recurrence

News

An immune therapy for the most aggressive form of breast cancer can substantially reduce the risk of the disease returning, according to a clinical trial led by Professor Peter Schmid of Queen Mary University of London.

READ MORE

Diabetes in Mice Cured Rapidly Using Human Stem Cell Strategy

News

After converting human stem cells into insulin-producing cells, researchers have demonstrated in mice infused with such cells that diabetes can be functionally cured for nine months.

READ MORE

Understanding Vaccine Hesitancy in China

News

Vaccine acceptance is a crucial public health issue, which has been exacerbated by the use of social media to spread content expressing vaccine hesitancy. Studies have shown that social media can provide new information regarding the dynamics of vaccine communication online, potentially affecting real-world vaccine behaviors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE